About Us
The Medical AI Promotion Institute (MAPI) aims to contribute to the health of all people and a better future
through the advancement of medical AI technology and its real-world implementation.
Here we introduce our mission and vision, our organization, our history,
and the leadership team behind these endeavors.
Through the power of medical AI, higher-quality healthcare and better health for everyone.
By promoting the safe and appropriate use of medical data and accelerating AI technology from R&D through real-world implementation, we work toward the following goals.
Advancing diagnosis and treatment
We contribute to earlier disease detection, improved diagnostic accuracy, and individually optimized treatment through AI.
Improving efficiency and reducing burden in clinical practice
We support the work of healthcare professionals and foster environments that enable more patient-centered care.
Accelerating drug and medical device development
Using data and AI, we enhance the R&D process for pharmaceuticals and medical devices,
promoting responses to unmet medical needs.
Promoting preventive medicine and better health
Through health prediction and personalized prevention, we contribute to extending healthy life expectancy.
To lead the real-world implementation of medical AI
and build a healthcare ecosystem of trust and co-creation whose benefits everyone can share.
As a central player in medical AI in Japan, MAPI envisions and works toward the following future.
Realizing data-driven healthcare
We build an environment where high-quality, diverse medical data is shared and utilized ethically and safely,
and where optimal, evidence-based care reaches all of society.
Forming an open innovation hub
We create a cycle in which medical institutions, research institutes, companies, government, and citizens collaborate across boundaries,
and new insights and technologies in medical AI are born, nurtured, and implemented.
A trusted platform
Handling medical information with strong ethics and transparency,
we establish a fair and sustainable foundation trusted by all stakeholders.
| Company name | Medical AI Promotion Institute, Inc. |
|---|---|
| Established | November 8, 2023 |
| Capital | ¥100 million |
| Fiscal year-end | September |
| Employees | 20 |
|---|---|
| Officers |
Director General Yuki Shimahara Representative Director Sho Kawabe Director Hiroaki Hyakutake Director Takeshi Ide Director Daiju Ueda Director Tomohiro Kikuchi Director Ryo Sato Director Hidetaka Kojima Outside Director Jo Sakai Outside Director Naoko Kato Outside Director Sumireko Sekiguchi Part-time Auditor Akio Kamiyama |
| Business |
Creation and provision of anonymized and pseudonymized medical information under the Next-Generation Medical Infrastructure Act Development and operation of infrastructure for collecting, curating, and analyzing medical data R&D support and consulting for medical AI (artificial intelligence) Regulatory compliance support and security consulting for medical information All other business incidental or related to the above |
|---|
Contact:
Email: info@mapi-jp.org (main)
Directions:
- 3 min. walk from Bakuro-yokoyama Station (Toei Shinjuku Line)
- 4 min. walk from Bakurocho Station (JR Sobu Line)
- 5 min. walk from Kodemmacho Station (Hibiya Line)
Director General
Representative Director
Director
Director
Director
Director
Director
Director
Outside Director
Outside Director
Outside Director
Part-time Auditor
Director General
Representative Director
Director
Director
Director
Director
Director
Director
Outside Director
Outside Director
Outside Director
Part-time Auditor
Here are the key milestones from MAPI's founding to the present. We continue to build a history of challenge and innovation in medical AI.
